ATAI is no longer actively traded. Data shown reflects verified historical relationships.
2Suppliers
1Customers
3Debt Items
20Related Chains

AtaiBeckley Inc. Suppliers

TickerNameConfidenceEvidence
JEFFERIES-LLC JEFFERIES-LLC 90% Under the Sales Agreement, the Company will set the parameters for the sale of Common Stock, the number of shares of Common Stock to be issued, the dates on which such sales are anticipated to be mad…
NUALTIS NUALTIS 90% We recognized $0.7 million in research and development services revenue for the three months ended September 30, 2025 related to certain research and development services performed by Nualtis for its…

AtaiBeckley Inc. Customers

TickerNameConfidenceEvidence
OTSUKA OTSUKA 85% The revenue recognized for the nine months ended September 30, 2024 is related to our license agreement with Otsuka.

AtaiBeckley Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ATAI-DEBT-7912 Xbrl Convertible 90% xbrl convertible detail from xbrl 2024-12-31.
ATAI-DEBT-7911 Warrants outstanding: 0 90% xbrl warrant detail from xbrl 2022-12-31.
ATAI-DEBT Debt stack $2.0M 90% Market cache reports total debt of $2.0M.

AtaiBeckley Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for AtaiBeckley Inc..

AtaiBeckley Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for AtaiBeckley Inc..

AtaiBeckley Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
RCUS Arcus Biosciences, Inc. 100.00 2
BCYC Bicycle Therapeutics plc 100.00 2
DYN Dyne Therapeutics, Inc. 100.00 2
HTGC Hercules Capital, Inc. 100.00 1 ['receiving']
IRON Disc Medicine, Inc. 100.00 2
SVRA Savara Inc. 100.00 2
ALT Altimmune, Inc. 100.00 2
ALEC Alector, Inc. 100.00 2
CMPS COMPASS Pathways plc 100.00 1 ['receiving']
ENGN enGene Therapeutics Inc. 100.00 2
VRDN Viridian Therapeutics, Inc. 100.00 2
KURA Kura Oncology, Inc. 100.00 2
OBIO Orchestra BioMed Holdings, Inc. 100.00 2
MDGL Madrigal Pharmaceuticals, Inc. 100.00 2
PHGE BiomX Inc. 100.00 2
SGHT Sight Sciences, Inc. 100.00 2
MAZE Maze Therapeutics, Inc. 100.00 2
REPL Replimune Group, Inc. 100.00 2
OTSUKA OTSUKA 54.19 1 ['receiving']
PHAT Phathom Pharmaceuticals, Inc. 50.00 2